Leading the way in Goal-Directed Haemodynamic Therapy

Clinically proven to Reduce Avoidable Complications

Reducing overall risk of complication by half, and even more dramatic reduction in specific complications such as acute kidney injury, points to the significant  potential of ODM technology if adopted as standard of care

Professor Jose María Calvo Vecino, Chief of Anaesthesia and Intensive Care, University of Salamanca, Spain, lead researcher in FEDORA 420 patient RCT, pub March 2018

Surgical Use of ODM+

The CardioQ-ODM+(ODM) monitor delivers accurate and real-time data in the perioperative setting. Clinicians can therefore operate a precision Goal-Directed Haemodynamic Therapy(GDHT) protocol to guide fluid and drug administration during major and high risk surgery. ODM is clinically proven to significantly reduce avoidable postoperative haemodynamic complications.


Critical Care Use of ODM+

CardioQ-ODM+ allows clinicians to guide fluid and drug administration during major and high risk surgery and in the critical care setting. The monitors are clinically proven and when used to guide Fluid Management reduce postoperative complications; intensive care admissions, intensive care stay, length of hospital stay and costs.

See our products

Paediatric Use of ODM+

The measurement of descending aortic blood flow is available for paediatric patients to safely and quickly monitor haemodynamic changes and guide therapy appropriately.

See our products